NIH-funded research Fellowship grant

Understanding how immune cells develop in the upper respiratory tract

Official title: CD8+ TRM Development and Maintenance in the Upper Respiratory Tract

Funded at Emory University · NIH-10997815 · Data updated 2026-11-12

This study is looking at how certain immune cells in your upper respiratory system help protect you from the flu, especially when there are no flu germs around, and it aims to find out how these cells can be better trained to fight off severe respiratory infections after vaccination.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionEmory University
NIH-funded
Lab location1 site (Atlanta, United States)
Project startAugust 15, 2024
Project endAugust 14, 2026
Funding year2024
Award (this year)$48,974
NIH project number1F31HL176090-01
Project IDNIH-10997815 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who are at risk of influenza infections, particularly those with compromised immune systems or chronic respiratory conditions.

Less likely to help

Patients who are not at risk for respiratory infections or those who have already developed strong immunity to influenza may not benefit from this research.

What this research studies

This research investigates the development and maintenance of CD8+ tissue-resident memory T cells (TRM) in the upper respiratory tract, which are crucial for protecting against influenza infections. The study aims to identify the signals and conditions necessary for these immune cells to form, especially when local antigens are absent. By examining how these cells respond to influenza vaccination and their role in preventing severe respiratory infections, the research seeks to enhance our understanding of immune protection in the respiratory system.

Why it matters

Potential benefit: If successful, this research could lead to improved vaccination strategies that provide better protection against influenza and potentially other respiratory infections.

How similar studies have gone: Previous research has shown success in understanding immune responses in the lungs, but the specific focus on upper respiratory tract CD8+ TRM development is relatively novel.

Where this research is happening

  • Emory University
    Atlanta, United States
    Active

Researchers

  • Principal investigator: Kost, Kirsten — Emory University
  • Study coordinator: Kost, Kirsten

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.